Congenital Disorders of the Optic Nerve GN Dutton 1039
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Whole Exome Sequencing Gene Package Vision Disorders, Version 6.1, 31-1-2020
Whole Exome Sequencing Gene package Vision disorders, version 6.1, 31-1-2020 Technical information DNA was enriched using Agilent SureSelect DNA + SureSelect OneSeq 300kb CNV Backbone + Human All Exon V7 capture and paired-end sequenced on the Illumina platform (outsourced). The aim is to obtain 10 Giga base pairs per exome with a mapped fraction of 0.99. The average coverage of the exome is ~50x. Duplicate and non-unique reads are excluded. Data are demultiplexed with bcl2fastq Conversion Software from Illumina. Reads are mapped to the genome using the BWA-MEM algorithm (reference: http://bio-bwa.sourceforge.net/). Variant detection is performed by the Genome Analysis Toolkit HaplotypeCaller (reference: http://www.broadinstitute.org/gatk/). The detected variants are filtered and annotated with Cartagenia software and classified with Alamut Visual. It is not excluded that pathogenic mutations are being missed using this technology. At this moment, there is not enough information about the sensitivity of this technique with respect to the detection of deletions and duplications of more than 5 nucleotides and of somatic mosaic mutations (all types of sequence changes). HGNC approved Phenotype description including OMIM phenotype ID(s) OMIM median depth % covered % covered % covered gene symbol gene ID >10x >20x >30x ABCA4 Cone-rod dystrophy 3, 604116 601691 94 100 100 97 Fundus flavimaculatus, 248200 {Macular degeneration, age-related, 2}, 153800 Retinal dystrophy, early-onset severe, 248200 Retinitis pigmentosa 19, 601718 Stargardt disease -
Bass – Glaucomatous-Type Field Loss Not Due to Glaucoma
Glaucoma on the Brain! Glaucomatous-Type Yes, we see lots of glaucoma Field Loss Not Due to Not every field that looks like glaucoma is due to glaucoma! Glaucoma If you misdiagnose glaucoma, you could miss other sight-threatening and life-threatening Sherry J. Bass, OD, FAAO disorders SUNY College of Optometry New York, NY Types of Glaucomatous Visual Field Defects Paracentral Defects Nasal Step Defects Arcuate and Bjerrum Defects Altitudinal Defects Peripheral Field Constriction to Tunnel Fields 1 Visual Field Defects in Very Early Glaucoma Paracentral loss Early superior/inferior temporal RNFL and rim loss: short axons Arcuate defects above or below the papillomacular bundle Arcuate field loss in the nasal field close to fixation Superotemporal notch Visual Field Defects in Early Glaucoma Nasal step More widespread RNFL loss and rim loss in the inferior or superior temporal rim tissue : longer axons Loss stops abruptly at the horizontal raphae “Step” pattern 2 Visual Field Defects in Moderate Glaucoma Arcuate scotoma- Bjerrum scotoma Focal notches in the inferior and/or superior rim tissue that reach the edge of the disc Denser field defects Follow an arcuate pattern connected to the blind spot 3 Visual Field Defects in Advanced Glaucoma End-Stage Glaucoma Dense Altitudinal Loss Progressive loss of superior or inferior rim tissue Non-Glaucomatous Etiology of End-Stage Glaucoma Paracentral Field Loss Peripheral constriction Hereditary macular Loss of temporal rim tissue diseases Temporal “islands” Stargardt’s macular due -
Optic Nerve Hypoplasia Plus: a New Way of Looking at Septo-Optic Dysplasia
Optic Nerve Hypoplasia Plus: A New Way of Looking at Septo-Optic Dysplasia Item Type text; Electronic Thesis Authors Mohan, Prithvi Mrinalini Publisher The University of Arizona. Rights Copyright © is held by the author. Digital access to this material is made possible by the University Libraries, University of Arizona. Further transmission, reproduction or presentation (such as public display or performance) of protected items is prohibited except with permission of the author. Download date 29/09/2021 22:50:06 Item License http://rightsstatements.org/vocab/InC/1.0/ Link to Item http://hdl.handle.net/10150/625105 OPTIC NERVE HYPOPLASIA PLUS: A NEW WAY OF LOOKING AT SEPTO-OPTIC DYSPLASIA By PRITHVI MRINALINI MOHAN ____________________ A Thesis Submitted to The Honors College In Partial Fulfillment of the Bachelors degree With Honors in Physiology THE UNIVERSITY OF ARIZONA M A Y 2 0 1 7 Approved by: ____________________________ Dr. Vinodh Narayanan Center for Rare Childhood Disorders Abstract Septo-optic dysplasia (SOD) is a rare congenital disorder that affects 1/10,000 live births. At its core, SOD is a disorder resulting from improper embryological development of mid-line brain structures. To date, there is no comprehensive understanding of the etiology of SOD. Currently, SOD is diagnosed based on the presence of at least two of the following three factors: (i) optic nerve hypoplasia (ii) improper pituitary gland development and endocrine dysfunction and (iii) mid-line brain defects, including agenesis of the septum pellucidum and/or corpus callosum. A literature review of existing research on the disorder was conducted. The medical history and genetic data of 6 patients diagnosed with SOD were reviewed to find damaging variants. -
Ophthalmology
Ophthalmology Information for health professionals MEDICAL GENETIC TESTING FOR OPHTHALMOLOGY Recent technologies, in particularly Next Generation Sequencing (NGS), allows fast, accurate and valuable diagnostic tests. For Ophthalmology, CGC Genetics has an extensive list of medical genetic tests with clinical integration of results by our Medical Geneticists. 1. EXOME SEQUENCING: Exome Sequencing is a very efficient strategy to study most exons of a patient’s genome, unraveling mutations associated with specific disorders or phenotypes. With this diagnostic strategy, patients can be studied with a significantly reduced turnaround time and cost. CGC Genetics has available 2 options for Exome Sequencing: • Whole Exome Sequencing (WES), which analyzes the entire exome (about 20 000 genes); • Disease Exome by CGC Genetics, which analyzes about 6 000 clinically-relevant genes. Any of these can be performed in the index case or in a Trio. 2. NGS PANELS For NGS panels, several genes associated with the same phenotype are simultaneously sequenced. These panels provide increased diagnostic capability with a significantly reduced turnaround time and cost. CGC Genetics has several NGS panels for Ophthalmology that are constantly updated (www.cgcgenetics.com). Any gene studied in exome or NGS panel can also be individually sequenced and analyzed for deletion/duplication events. 3. EXPERTISE IN MEDICAL GENETICS CGC Genetics has Medical Geneticists specialized in genetic counseling for ophthalmological diseases who may advice in choosing the most appropriate -
TUBB3 M323V Syndrome Presents with Infantile Nystagmus
G C A T T A C G G C A T genes Case Report TUBB3 M323V Syndrome Presents with Infantile Nystagmus Soohwa Jin 1, Sung-Eun Park 2, Dongju Won 3, Seung-Tae Lee 3, Sueng-Han Han 2 and Jinu Han 4,* 1 Department of Opthalmology, Yonsei University College of Medicine, Seoul 03722, Korea; [email protected] 2 Department of Ophthalmology, Institute of Vision Research, Severance Hospital, Yonsei University College of Medicine, Seoul 03722, Korea; [email protected] (S.-E.P.); [email protected] (S.-H.H.) 3 Department of Laboratory Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul 03722, Korea; [email protected] (D.W.); [email protected] (S.-T.L.) 4 Department of Ophthalmology, Institute of Vision Research, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul 06273, Korea * Correspondence: [email protected]; Tel.: +82-2-2019-3445 Abstract: Variants in the TUBB3 gene, one of the tubulin-encoding genes, are known to cause congenital fibrosis of the extraocular muscles type 3 and/or malformations of cortical development. Herein, we report a case of a 6-month-old infant with c.967A>G:p.(M323V) variant in the TUBB3 gene, who had only infantile nystagmus without other ophthalmological abnormalities. Subsequent brain magnetic resonance imaging (MRI) revealed cortical dysplasia. Neurological examinations did not reveal gross or fine motor delay, which are inconsistent with the clinical characteristics of patients with the M323V syndrome reported so far. A protein modeling showed that the M323V mutation in the TUBB3 gene interferes with αβ heterodimer formation with the TUBA1A gene. -
Orphanet Report Series Rare Diseases Collection
Marche des Maladies Rares – Alliance Maladies Rares Orphanet Report Series Rare Diseases collection DecemberOctober 2013 2009 List of rare diseases and synonyms Listed in alphabetical order www.orpha.net 20102206 Rare diseases listed in alphabetical order ORPHA ORPHA ORPHA Disease name Disease name Disease name Number Number Number 289157 1-alpha-hydroxylase deficiency 309127 3-hydroxyacyl-CoA dehydrogenase 228384 5q14.3 microdeletion syndrome deficiency 293948 1p21.3 microdeletion syndrome 314655 5q31.3 microdeletion syndrome 939 3-hydroxyisobutyric aciduria 1606 1p36 deletion syndrome 228415 5q35 microduplication syndrome 2616 3M syndrome 250989 1q21.1 microdeletion syndrome 96125 6p subtelomeric deletion syndrome 2616 3-M syndrome 250994 1q21.1 microduplication syndrome 251046 6p22 microdeletion syndrome 293843 3MC syndrome 250999 1q41q42 microdeletion syndrome 96125 6p25 microdeletion syndrome 6 3-methylcrotonylglycinuria 250999 1q41-q42 microdeletion syndrome 99135 6-phosphogluconate dehydrogenase 67046 3-methylglutaconic aciduria type 1 deficiency 238769 1q44 microdeletion syndrome 111 3-methylglutaconic aciduria type 2 13 6-pyruvoyl-tetrahydropterin synthase 976 2,8 dihydroxyadenine urolithiasis deficiency 67047 3-methylglutaconic aciduria type 3 869 2A syndrome 75857 6q terminal deletion 67048 3-methylglutaconic aciduria type 4 79154 2-aminoadipic 2-oxoadipic aciduria 171829 6q16 deletion syndrome 66634 3-methylglutaconic aciduria type 5 19 2-hydroxyglutaric acidemia 251056 6q25 microdeletion syndrome 352328 3-methylglutaconic -
Multiple Ocular Developmental Defects in Four Closely Related Alpacas
Veterinary Ophthalmology (2018) 1–8 DOI:10.1111/vop.12540 CASE REPORT Multiple ocular developmental defects in four closely related alpacas Kelly E. Knickelbein,* David J. Maggs,§ Christopher M. Reilly,†,1 Kathryn L. Good*,2 and Juliet R. Gionfriddo‡,3 *The Veterinary Medical Teaching Hospital, University of California, Davis, CA 95616, USA; §Department of Surgical and Radiological Sciences, University of California, Davis, CA 95616 USA; †Department of Pathology Microbiology, and Immunology, University of California, Davis, CA 95616, USA; and ‡The College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80528, USA Address communications to: Abstract D. J. Maggs Objective To describe the clinical, gross pathologic, and histopathologic findings for a Tel.: (530) 752-3937 visually impaired 5.8-year-old female alpaca with multiple ocular abnormalities, as well Fax: (530) 752-6042 as the clinical findings for three closely related alpacas. e-mail: [email protected] Animals studied Four alpacas. Present addresses: 1Insight Procedures Ophthalmic examination was performed on a 16-month-old female alpaca Veterinary Specialty Pathology, following observation of visual impairment while hospitalized for an unrelated illness. Austin, TX 78752, USA Following acute systemic decline and death 4.5 years later, the alpaca’s brain, optic 2Department of Surgical and Radiological Sciences, nerves, and eyes were examined grossly and histologically. Ophthalmic examination of University of California, Davis, three closely related alpacas was subsequently performed. CA 95616, USA Results The 16-month-old female alpaca (Alpaca 1) had ophthalmoscopic findings sug- 3 Red Feather Lakes, CO 80545, gestive of a coloboma or hypoplasia of the retinal pigment epithelium (RPE) and chor- USA oid, and suspected optic nerve hypoplasia OU. -
Ocular Colobomaâ
Eye (2021) 35:2086–2109 https://doi.org/10.1038/s41433-021-01501-5 REVIEW ARTICLE Ocular coloboma—a comprehensive review for the clinician 1,2,3 4 5 5 6 1,2,3,7 Gopal Lingam ● Alok C. Sen ● Vijaya Lingam ● Muna Bhende ● Tapas Ranjan Padhi ● Su Xinyi Received: 7 November 2020 / Revised: 9 February 2021 / Accepted: 1 March 2021 / Published online: 21 March 2021 © The Author(s) 2021. This article is published with open access Abstract Typical ocular coloboma is caused by defective closure of the embryonal fissure. The occurrence of coloboma can be sporadic, hereditary (known or unknown gene defects) or associated with chromosomal abnormalities. Ocular colobomata are more often associated with systemic abnormalities when caused by chromosomal abnormalities. The ocular manifestations vary widely. At one extreme, the eye is hardly recognisable and non-functional—having been compressed by an orbital cyst, while at the other, one finds minimalistic involvement that hardly affects the structure and function of the eye. In the fundus, the variability involves the size of the coloboma (anteroposterior and transverse extent) and the involvement of the optic disc and fovea. The visual acuity is affected when coloboma involves disc and fovea, or is complicated by occurrence of retinal detachment, choroidal neovascular membrane, cataract, amblyopia due to uncorrected refractive errors, etc. While the basic birth anomaly cannot be corrected, most of the complications listed above are correctable to a great 1234567890();,: 1234567890();,: extent. Current day surgical management of coloboma-related retinal detachments has evolved to yield consistently good results. Cataract surgery in these eyes can pose a challenge due to a combination of microphthalmos and relatively hard lenses, resulting in increased risk of intra-operative complications. -
MAC-ASD Panel 16-Apr-2018 Versie Centrum Voor Medische Genetica Gent (59 Genen)
H9.1-OP2-B15: Genpanel MAC-ASD, 16-Apr-2018, in voege op 23/04/2018 MAC-ASD panel 16-Apr-2018 versie Centrum voor Medische Genetica Gent (59 genen) OMIM gene Associated phenotype, OMIM phenotype ID, phenotype mapping Gene ID key and inheritance pattern [Blood group, Langereis system], 111600 (3); Dyschromatosis universalis hereditaria 3, 615402 (3), Autosomal dominant; Microphthalmia, isolated, ABCB6 605452 with coloboma 7, 614497 (3), Autosomal dominant; Pseudohyperkalemia, familial, 2, due to red cell leak, 609153 (3), Autosomal dominant Microcornea, myopic chorioretinal atrophy, and telecanthus, 615458 (3), ADAMTS18 607512 Autosomal recessive ALDH1A3 600463 Microphthalmia, isolated 8, 615113 (3), Autosomal recessive ASPH 600582 Traboulsi syndrome, 601552 (3), Autosomal recessive Persistent hyperplastic primary vitreous, autosomal recessive, 221900 (3), ATOH7 609875 Autosomal recessive B3GLCT 610308 Peters-plus syndrome, 261540 (3), Autosomal recessive BCOR 300485 Microphthalmia, syndromic 2, 300166 (3), X-linked dominant Microphthalmia, syndromic 6, 607932 (3), Autosomal dominant; Orofacial BMP4 112262 cleft 11, 600625 (3) BMP7 112267 No OMIM phenotype C12orf57 615140 Temtamy syndrome, 218340 (3), Autosomal recessive CHARGE syndrome, 214800 (3), Autosomal dominant; Hypogonadotropic CHD7 608892 hypogonadism 5 with or without anosmia, 612370 (3), Autosomal dominant Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps, 611773 (3), Autosomal dominant; Brain small vessel disease with or without ocular anomalies, 607595 -
Without Retinopathy Ofprematurity 93
BritishJournalofOphthalmology 1993; 77:91-94 91 Follow-up study on premature infants with and without retinopathy of prematurity Br J Ophthalmol: first published as 10.1136/bjo.77.2.91 on 1 February 1993. Downloaded from Rosemary Robinson, Michael O'Keefe Abstract first screened at 6 weeks. When discharged from The ocular complications in population of 131 the neonatal unit, they continue to attend for premature infants, with and without retino- follow up at the Children's Hospital. Follow up pathy of prematurity (ROP) are reported. An is determined by the degree ofvascularisation of increased incidence of strabismus (20% with the retina. If fully vascularised, the child is seen ROP and 25% without ROP) and myopia again at 3 months and then yearly until age 5 (27-5% with ROP and 8-8% without ROP) was years, unless strabismus or amblyopia develop. shown. Significant visual loss occurred in If ROP is diagnosed, assessment is every 3-4 10-7% overall, increasing to 35% with stage 3 weeks if stage 1-2 is present and weekly if stage disease and 100% with stage 4. With the 3. If stage 3 threshold disease is noted then increased survival rate of premature infants, cryopexy is applied. After treatment, all infants the relevance to future management of this are seen at 3 monthly intervals for the first year expanding group of young people is and every 6 months for 5 years, then annually. considered. We classified ROP according to the (BrJ7 Ophthalmol 1993; 77: 91-94) international classification7 and defined signifi- cant ROP as stage 3 or 4 disease. -
I. Infants with Poor Vision
AAPOS Genetic Eye Disease Workshop 2019 I. Infants with poor vision 1. Infant with poor vision without nystagmus—Debbie Costakos Case #1: An ex 27-week CGA (Corrected Gestational Age) BW 1050g baby girl was referred at age 30 weeks for ROP. ROP resolved spontaneously but the patient was noted to have poor eye contact and no fix and follow at 6 months of age. PMHx was significant for prematurity, intraventricular hemorrhage (grade 3) and periventricular leukomalacia FHx was negative for poor vision Alignment was orthotropic CRx was +3.00 sphere in both eyes DFE revealed normal optic nerves, macula and vessels Case #2: A 6-month-old baby girl was referred at age 6 months for lack of eye contact and no fix and follow. PMHx was not significant FHx was negative for poor vision, strabismus or developmental delay Visual acuity was blinks to light both eyes Alignment was variable intermittent exotropia up to 40 PD X(T) CRx was +5.00 +1.00 x 90 and +4.50 +2.00 x 90 DFE revealed poor foveal reflex in both eyes with a blond fundus Use clinical findings, history and family history to guide the work up. Differential Diagnosis may include: Differential Diagnosis for Infant with poor vision, no nystagmus: Delayed Visual Maturation (DVM) Cortical Visual Impairment (CVI) Albinism Seizure disorder Metabolic disorders Prematurity with PVL, other CNS involvement (with or without ROP). Note: strabismus alone is not a diagnosis for bilateral poor vision Imaging tools are available Workup to consider: OCT—“normal” appearance varies by age ERG Referral to other specialists Brain mri Genetic testing, or not, depending on differential diagnosis and probably yield 2. -
British Journal of Ophthalmology January 1978 Vol. 62 No. 1 Br J Ophthalmol: First Published As on 1 January 1978
British Journal of Ophthalmology January 1978 Vol. 62 No. 1 Br J Ophthalmol: first published as on 1 January 1978. Downloaded from Contents Editorial: Small optic discs page 1 Maternal anticonvulsants and optic nerve hypoplasia CREIG S. HOYT and FRANK A. BILLSON page 3 Spectrum of optic nerve hypoplasia LARS FRISEN AND LARS HOLMEGAARD page 7 The tilted disc DAVID DORRELL page 16 Amblyopia resulting from penalisation: neurophysiological studies of kittens reared with atropinisation of one or both eyes HISAKO IKEDA and K. E. TREMAIN page 21 Pattern of amblyopia and fixation after keratoplasty G. SINGH and P. N. DAS page 29 Contrast threshold of random dot stereograms in anisometropic amblyopia: a clinical investigation I. C. J. WOOD, J. A. FOX, and M. G. STEPHENSON page 34 Posterior polymorphous keratopathy G. M. LIAKOS and T. A. CASEY page 39 http://bjo.bmj.com/ Histopathology of human superficial herpes simplex keratitis P. C. MAUDGAL and L. MISSOTTEN page 46 Histology of spheroidal degeneration of the cornea in Labrador GORDON J. JOHNSON and MARY OVERALL page 53 Keratitis from abuse of corneal anaesthetics HAROLD E. HENKES and THEODOR N. WAUBKE page 62 on October 4, 2021 by guest. Protected copyright. An illustration of an in-vivo corneal response to a soft lens presoaked in a non-isotonic solution A. J. KEMPSTER and J. R. LARKE page 66 Book reviews page 69 Obituary page 69 Correspondence page 70 Notes page 71 ASTM CODEN BJOPAL 62 (1) 1-72 (1978) ISSN 0007-1161 British Medical Association Tavistock Square London WC1H 9JR Br J Ophthalmol: first published as on 1 January 1978.